SLN
Silence TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
SLN vs peer average
72/100
SLN vs. peer average (C vs. D)
Grade spread
C 2 · D 3 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
FHTX is the first available peer comparator.
Less direct scientifically, but still a small-cap development-stage biotech with platform optionality and sentiment that swings with milestone cadence rather than current commercial revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SLN
Silence Therapeutics
FHTX
Foghorn Therapeutics
Grade
C
C
Momentum
52
63
Value
54
41
Sentiment
52
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs FHTX
SLN / FHTX
Grade Position
Above peers
SLN vs. peer average (C vs. D)
72/100
Momentum
52
FHTXValue
54
SLNSentiment
52
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SLN
FHTX is the first peer returned for this comparison set.